New York Times Examines Rapid HIV Testing, Debate Over OTC Use; Newsweek Profiles OraSure CEO, Oral HIV Test
November 8, 2005
The New York Times on Saturday examined rapid HIV testing -- which has become the center of the U.S. strategy to prevent the disease and some say has "revolutionized" testing -- and the debate surrounding FDA's consideration of a proposal to allow over-the-counter access to the test. Prior to the approval of the two currently available rapid tests in 2002 and 2004, most federal programs focused on encouraging HIV-negative people to make behavioral changes to prevent HIV infection. With the availability of rapid testing, CDC is directing its prevention efforts at encouraging people to undergo HIV testing to determine their status early, before they spread the virus to others and when treatment is more effective, according to Ronald Valdiserri, acting director of CDC's National Center for HIV, STD and TB Prevention (Leland, New York Times, 11/5). An FDA advisory committee on Thursday heard testimony on a proposal to allow consumers to use OraSure Technologies' OraQuick Advance Rapid HIV 1/2 Antibody Test at home (Kaiser Daily HIV/AIDS Report, 11/4). Proponents of at-home HIV testing say it will reduce stigma and other obstacles to testing, and research shows people are less likely to spread the virus if they learn they are HIV-positive, the Times reports. Opponents of home testing say that along with the results, patients need education and counseling. FDA approved an at-home HIV test in 1996, but users mail a blood sample to a laboratory and access the results through a telephone hotline that has access to counselors (New York Times, 11/5).
Newsweek Profiles OraSure CEO, OraQuick HIV Test
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2005 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.